What Promisemed does

Promisemed (普昂(杭州)医疗科技股份有限公司) is a privately-held Chinese medical device manufacturer founded in January 2013 and headquartered in Hangzhou, Zhejiang, China. The company focuses on the R&D, production, and sale of needle-based medical devices across three therapeutic areas: diabetes care (insulin pen needles, insulin syringes), oncology diagnostics (biopsy needles, endoscopic instruments), and drug delivery (implantable port needles, peripheral and heel blood collection devices). Its product portfolio includes disposable insulin pen needles marketed under the Changrui/Verifine brand (with gauges as fine as 33G / 0.20mm), the first domestically registered self-destructing insulin injection needle with international and EU patents, fully automatic and semi-automatic biopsy needles, blade-type heel blood collectors for newborn screening, vacuum negative-pressure blood collection pens, and disposable insulin syringes.

The company's underlying technology base comprises proprietary Superstick silicone oil coating for reduced penetration pain, a CCD automated production monitoring line that detects and auto-rejects burr and reverse-defective needles, dual-end self-destructing needle safety architecture, and a 33G ultra-thin needle manufacturing capability. The portfolio is supported by approximately 100 registered patents.

Promisemed operates a dual-channel go-to-market model. Domestically, the company sells through regional dealer networks and a direct sales team covering 22 Chinese provinces and municipalities, with multiple named regional sales managers coordinating distributor relationships. Internationally, products reach 12 countries (US, Germany, France, Spain, Italy, Netherlands, UK, Finland, Turkey, Saudi Arabia, Malaysia) through in-country distributors. Revenue is generated through hardware sales of registered medical devices; key products are covered by medical insurance in five Chinese provinces/municipalities (Zhejiang, Jiangsu, Shanghai, Tianjin, Guangdong). The company has achieved FDA, CE, MDSAP, and EU MDR certifications, including a zero-defect FDA on-site audit in March 2015 and EU MDR certification in July 2021 — among the earliest Chinese device makers to obtain CE under the new MDR framework.

Name

Promisemed

Legal name

普昂(杭州)医疗科技股份有限公司

Website

https://promisemed.cn

Company type

Private

Founded year

2013

Operating status

Operating

Short description

Promisemed is a Hangzhou-based medical device manufacturer founded in 2013 that develops and sells disposable needle-based devices — including insulin pen needles, biopsy needles, blood collection devices, and drug delivery needles — for diabetes, oncology, and neonatal screening applications across China and 12 international markets.

Ownership category

akta.pro rank

Product category

Medical Devices (Diabetes and Injection Systems)

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (33911)

SIC

Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Insulin Pen Needles, Syringes & Infusion Sets (Consumables) (HLAHAHAE)

akta.pro secondary industry

Diabetes Care Device Accessories & Adhesives (Sensors/Pump Supplies) (HLAHAHAL)

Keywords

• Diabetes medical devices
• Insulin injection needles
• Biopsy needles
• Blood collection devices
• Drug delivery systems

Headquarters

HQ city

Hangzhou

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Medical Device and Consumable Sales: Revenue generated from the sale of medical devices and consumables including insulin injection pen needles, blood collection needles, biopsy needles, lancets, and drug delivery systems. Products are sold domestically in China with registration certificates and internationally through CE, FDA, and MDR certifications.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Promisemed designs, manufactures, and sells disposable needle-based medical devices, with a primary focus on insulin injection pen needles for diabetes patients and a secondary portfolio covering biopsy needles, blood collection devices (peripheral and heel), and implantable drug delivery needles. The company sells under the Promisemed, 畅锐 (Changrui/Verifine), and 滁臻 brands, distributing through domestic regional dealers across 22 Chinese provinces and international distributors across 12 countries, holding FDA, CE, ISO 13485, MDSAP, and EU MDR certifications.

Product overview

Promisemed (普昂医疗) is a medical device manufacturer specializing in diabetes treatment, oncology diagnosis and treatment, and drug delivery systems. The company offers a comprehensive portfolio of needle-based medical devices including insulin injection pen needles (畅锐/Verifine brand), blood collection devices (peripheral blood collection needles, heel blood collectors, blood collection pens), biopsy needles (fully automatic, semi-automatic, and puncture types), endoscopic instruments (forceps, cell brushes), and safety devices (self-destructing needles, sharp instrument containers). The product portfolio is organized around three core therapeutic areas: diabetes management (insulin needles, syringes, blood glucose collection), diagnostic biopsy (various biopsy needles and endoscopic tools), and drug delivery systems (implantable device needles). Key technologies include proprietary Superstick silicone coating, CCD automated production monitoring for quality control, and safety designs (self-destructing mechanisms, safety locks). Products are sold under the Promisemed and 畅锐 (Changrui)/Verifine brands, with regulatory approvals including FDA, CE, MDSAP, and domestic Chinese medical device registration.

Differentiator

Problem solved

Functional benefit

Brands

• 畅锐 (Changrui): 普昂医疗的胰岛素注射针头和采血系列产品品牌，包括一次性使用胰岛素注射笔用针头、一次性使用足跟采血器等核心产品。
• Verifine
• 溦臻

Products and services

• Changrui Verifine Disposable Insulin Injection Pen Needle (一次性使用胰岛素注射笔用针头 - 畅锐/Verifine) Disposable insulin pen needle compatible with most insulin pens on the market, designed for daily subcutaneous insulin injection by diabetes patients. Features Superstick silicone coating technology, CCD automated quality monitoring, and a triple-faceted 33G (0.20mm) needle tip for minimal injection pain.
• Disposable Self-Destructing Insulin Pen Needle (一次性使用自毁型注射笔用针头) China's first domestically registered safety self-destructing insulin pen needle with dual-ended protection that automatically locks after use. Designed for diabetes patients and healthcare workers to prevent needlestick injuries and reuse, holding international and EU patents.
• Disposable Injection Pen Needle - Large Flat Head (一次性使用注射笔用针头 - 大平头) Disposable injection pen needle with a large flat-head design featuring an injection force area approximately 7x larger than standard needles, providing more stable injection and reducing pressure marks and bruising for diabetes patients.
• Disposable Sterile Insulin Syringe (ISY) (一次性使用无菌胰岛素注射器) Disposable sterile insulin syringe for drawing and subcutaneous injection of insulin, designed with extremely low residual (LDS) volume, precise measurement, and smooth needle insertion to minimize pain for diabetes patients.
• Disposable Heel Blood Collector (一次性使用足跟采血器 - 畅锐) Disposable blade-type heel blood collector for newborn heel blood screening (phenylketonuria and congenital hypothyroidism). Features dual-track trapezoidal incision, anti-slip ergonomic housing, precision puncture control with 0.2mm blade thickness to reduce infant pain and tissue fluid contamination.
• Disposable Fully Automatic Biopsy Needle (一次性使用全自动活检针) Fully automatic disposable biopsy needle for obtaining tissue samples from liver, spleen, kidney, prostate, breast, lymph nodes, and soft tissue tumors. Used by hospital departments in ultrasound, oncology, urology, breast surgery, and interventional radiology.
• Disposable Semi-Automatic Biopsy Needle (一次性使用半自动活检针) Semi-automatic disposable biopsy needle with dual-stroke sampling, lightweight construction, compact structure, and minimal trigger vibration, intended for clinical soft tissue sampling.
• Disposable Puncture Biopsy Needle (一次性使用穿刺活检针) Disposable puncture biopsy needle designed for organ intervention to obtain cytology samples, featuring sharp puncture capability for accurate biopsy sampling in clinical settings.
• Disposable Integrated Biopsy Needle (一次性一体式活检针 - BN 2nd Generation) Multi-purpose disposable integrated biopsy needle offering a unified puncture biopsy solution for clinical use, designed to combine multiple biopsy functions in a single device for healthcare practitioners.
• Disposable Peripheral Blood Collection Needle - Safety Lock Card Type (一次性使用末梢采血针 - 安全锁卡式) Disposable peripheral blood collection needle with safety lock card-type design. Features a spring-loaded mechanism that automatically locks after use to prevent reuse and reduce needlestick injuries. Used with a blood collection pen for capillary blood sampling.
• Disposable Peripheral Blood Collection Needle - Safety Lock M-Type (一次性使用末梢采血针 - 安全锁卡式M型) M-type disposable peripheral blood collection needle with safety lock and standalone operation that does not require matching with a blood collection pen. Automatically locks after use to prevent reuse and needlestick injuries.
• Disposable Twist-Type Peripheral Blood Collection Needle (一次性使用末梢采血针 - 扭式) Disposable twist-type peripheral blood collection needle for clinical finger and ear blood collection, designed for use with a matching blood collection pen (lancet device).
• Weizhen Negative Pressure Painless Blood Collection Pen (滁臻负压无痛采血笔) Negative pressure painless blood collection pen using vacuum adsorption to reach shallow comfort-zone capillaries. Features dual-track spring ejection for precise stable puncture with minimal pain, one-click trigger and release, and adjustable depth for blood glucose monitoring.
• Negative Pressure Blood Collection Pen (负压采血笔) Negative pressure blood collection pen designed for shallow, painless capillary blood collection via vacuum adsorption. Used for comfortable blood glucose and other capillary blood sampling.
• Blood Collection Pen (采血笔) Blood collection pen (triggering device) used with disposable twist-type peripheral blood collection needles for capillary blood sampling in clinical and home settings.
• Implantable Drug Delivery Device Dedicated Needle (植入式给药装置专用针) Specialized needle for implantable drug delivery ports, designed with high-elasticity TPU tubing for smooth infusion. Used in oncology settings for chemotherapy administration and other long-term drug infusion therapies, featuring anti-needle-stick design to reduce cross-infection.
• Disposable Tissue Sampling Forceps (一次性活组织取样钳) Disposable tissue sampling forceps for soft endoscopic biopsy procedures, designed to enable quick and reliable tissue sampling with precise positioning during endoscopic examinations.
• Disposable Endoscopic Forceps (一次性使用内镜抓钳) Disposable endoscopic forceps designed to enter natural body cavities through flexible endoscope channels. Used to grasp stones, foreign objects, or resected tissue with 1:1 coaxial rotation control.
• Disposable Cell Brush (一次性使用细胞刷) Disposable cell brush with dense bristles for extracting tissue samples during endoscopic examinations, enabling thorough cytology sampling in clinical settings.
• Disposable Sharp Instrument Container (一次性使用锐器收纳盒) Disposable sharp instrument container designed for safely collecting discarded insulin needles and other sharps. Allows single-hand operation for needle replacement, helping prevent accidental injuries from discarded sharps in home and clinical settings.

Quantifiable outcome

• Needle gauge as fine as 33G (0.20mm outer diameter) — thinnest available in the category, significantly reducing injection pain
• +4 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• 国内多家知名企业 (Multiple Domestic Well-Known Enterprises)moderateOthersPromisemed has established long-term strategic partnerships with multiple well-known domestic enterprises in China. Six core products have obtained domestic medical device registration certificates and entered the market since 2019, with ongoing strategic cooperation with major manufacturers and distributors across China.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Shanghai Kindly Enterprise Development Group (康德莱): Kindly is a Chinese specialist manufacturer of needles, syringes, and injection devices with significant export business. Its core product lines—including insulin pen needles, safety needles, and blood collection devices—directly mirror Promisemed's portfolio, making it the closest direct domestic peer by product mix.
• Ypsomed Holding AG: Ypsomed is a Swiss specialist in pen injector platforms and self-injection systems, including pen needles compatible with its YpsoMate and other platforms. Ypsomed's pen injection and pen needle product lines are highly comparable to Promisemed's insulin pen needle business and target similar pharmaceutical partners and self-pay consumers.
• Shandong Weigao Group Medical Polymer Company Limited: Weigao is one of China's largest medical device manufacturers, with extensive production of injection needles, syringes, blood collection devices, and IV consumables. As a domestic Chinese competitor with overlapping product categories, Weigao is among the most direct competitors to Promisemed in both hospital procurement and export markets.
• HTL-STREFA S.A. HTL-STREFA is a Polish-based manufacturer specializing in safety lancets, pen needles, and capillary blood collection devices. Its focused product portfolio and safety-device emphasis make it a comparable specialty peer to Promisemed's self-destructing needle and blood collection pen product lines, particularly in European tender markets.
• Becton, Dickinson and Company (BD): BD is the global leader in injection and infusion medical devices, including insulin pen needles, safety needles, and biopsy needles. BD's Diabetes Care and Medical Surgical segments directly overlap with Promisemed's insulin pen needle, self-destructing safety needle, and biopsy needle product lines, making it the most direct large-scale peer.
• Terumo Corporation: Terumo is a Japanese medical device manufacturer with a leading global position in injection needles, syringes, and blood collection devices. Its Hypodermic Needle, Syringe, and Blood Bag divisions directly compete with Promisemed's insulin needles, disposable syringes, peripheral blood collection needles, and heel blood collection products.
• Nipro Corporation: Nipro is a Japanese medical device manufacturer with substantial operations in needles, syringes, and injection systems for diabetes care. Its dialyzer, injection, and diabetes segments produce pen needles and safety needles comparable to Promisemed's product range, with similar international export profiles.
• Owen Mumford: Owen Mumford is a UK-based specialist manufacturer of pen needles, auto-injectors, and lancets under brands including Unifine. As a focused mid-sized needle/safety device specialist with strong EU distribution, Owen Mumford is one of the closest functional and scale analogues to Promisemed's insulin pen needle and self-destructing safety needle portfolio.

Broad incumbents

• B. Braun SE: B. Braun is a major German diversified medical device and pharmaceutical company offering pen needles, syringes, infusion systems, and surgical instruments. While far larger and broader than Promisemed, its Injectables and Diabetes Care divisions overlap directly with Promisemed's insulin needle, syringe, and drug delivery needle products, particularly in EU markets where it has hospital procurement strength.
• ICU Medical, Inc. (formerly Smiths Medical): ICU Medical acquired Smiths Medical and operates a broad portfolio of injection, infusion, and safety devices including pen needles and blood collection products. While a larger diversified incumbent, its needle and safety device lines compete directly with Promisemed in international hospital channels, especially in the US and UK markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Promisemed